What is JNJ stock price today?

JNJ (Johnson & Johnson) stock is trading at $232.77 as of the latest market data. Stock prices update in real-time during market hours (9:30 AM - 4:00 PM ET).

Is JNJ stock going up or down today?

JNJ stock price movements are influenced by market conditions, news, earnings reports, and investor sentiment. Check our live dashboard for real-time price changes and technical indicators.

Should I buy JNJ stock now?

The decision to buy JNJ depends on your investment strategy, risk tolerance, and financial goals. Our AI analysis evaluates fundamentals, valuation metrics, growth prospects, and market conditions to help inform your decision.

Is JNJ a buy, hold, or sell right now?

Our AI-powered analysis provides buy/hold/sell recommendations for JNJ based on multiple factors including valuation, growth metrics, technical indicators, and analyst consensus. Visit our dashboard for the latest recommendation.

Is JNJ stock overvalued or undervalued?

JNJ currently trades at a P/E ratio of 17.35 relative to earnings. Our DCF calculator provides intrinsic value estimates to help determine if JNJ is fairly priced.

What is JNJ's P/E ratio?

JNJ has a price-to-earnings (P/E) ratio of 17.35, which measures how much investors are willing to pay per dollar of earnings. Compare this to industry peers and historical averages for context.

What is JNJ's market cap?

JNJ (Johnson & Johnson) has a market capitalization of $375.37 billion, making it a large-cap stock.

What is JNJ's price to book ratio?

Price-to-book ratio for JNJ is available on our dashboard along with other valuation metrics.

Does JNJ pay dividends?

Yes, JNJ pays dividends with a current yield of 3.40%. Dividend payments provide income for investors in addition to potential stock price appreciation.

What is JNJ's dividend yield?

JNJ's dividend yield is 3.40%, calculated as annual dividends divided by the current stock price. This represents the annual return from dividends alone.

Is JNJ stock a good long-term investment?

JNJ's long-term investment potential depends on sustainable competitive advantages, revenue growth, profitability, management quality, and industry dynamics. Our AI analysis evaluates these factors to assess long-term prospects.

What is JNJ's revenue growth rate?

Revenue growth data for JNJ is available on our dashboard with detailed financial statement analysis.

Profitability metrics for JNJ are available on our dashboard with complete income statement analysis.

What are the risks of investing in JNJ?

Key risks for JNJ include market volatility, competitive pressures, regulatory changes, economic conditions, execution risks, and company-specific factors. Our AI analysis identifies material risks and their potential impact on valuation.

How does JNJ compare to its competitors?

Compare JNJ to industry peers on our dashboard using metrics like P/E ratio, revenue growth, profit margins, market share, and valuation multiples. Competitive analysis helps contextualize JNJ's performance and positioning.

What is JNJ's stock price target for 2026?

Our AI model provides price targets for JNJ based on fundamental analysis: Bull case $302.60 (+30%), Base case $267.69 (+15%), Bear case $209.49 (-10%). Visit our prediction page for detailed forecasts.

What do analysts say about JNJ?

Wall Street analysts provide ratings (buy/hold/sell) and price targets for JNJ. Our dashboard aggregates analyst consensus, target prices, and recent upgrades/downgrades to help you understand professional sentiment.

When is JNJ's next earnings report?

JNJ reports earnings quarterly. Check our dashboard for the upcoming earnings date, analyst estimates for revenue and EPS, and historical earnings performance. Earnings reports often drive significant stock price movements.

JNJ - Johnson & Johnson

NYSE * Healthcare * Drug Manufacturers - General

$232.77

+$4.60 (+2.02%)

About Johnson & Johnson

Johnson & Johnson (JNJ) common stock

Price Chart

Loading chart...

JNJ Key Statistics

Market Cap

$375.37B

P/E Ratio

17.35

Dividend Yield

3.40%

How JNJ Compares to Peers

JNJ has the lowest P/E ratio in Drug Manufacturers - General, suggesting it may be the most undervalued

JNJ is the largest company in its peer group by market cap

P/E Rank

of 3

Margin Rank

N/A

of 0

Growth Rank

N/A

of 0

Size Rank

of 3

Company	Market Cap	P/E	Growth	Margin	Compare
JNJ(This stock)	$375.37B	17.4	0%	0.0%	-
ABBVAbbVie Inc	$334.34B	80.5	0%	0.0%	vs ABBV
BMYBristol-Myers Squibb	$95.36B	17.5	0%	0.0%	vs BMY

Data Updated: June 15, 2026 at 4:45 AM EDT

Ready to invest in JNJ?

Commission-free trading available. Affiliate links.

JNJ Lician Score

14% confidence

4.0/10

Neutral

JNJ has a Lician Score of 4/10 (Average). Areas of concern: Growth, Quality.

value

5.0

growth

3.0

quality

2.0

momentum

5.0

safety

5.0

The Lician Score is a comprehensive 1-10 rating that evaluates JNJacross five key dimensions: Value (valuation relative to sector),Growth (revenue and earnings trajectory),Quality (profitability and balance sheet strength),Momentum (price trends and analyst sentiment), andSafety (volatility and risk metrics).

JNJ Financial Snowflake

5-axis analysis across key investment dimensions

4.0/10

Neutral

5.0

Value

Valuation vs. sector peers

3.0

Growth

Revenue & earnings trajectory

2.0

Quality

Profitability & moat strength

5.0

Momentum

Price trends & analyst sentiment

5.0

Safety

Financial stability & risk

Upcoming Events for JNJ

Dashboard

Enter a ticker to analyze